International Edition
Latest News
Health

Retinitis pigmentosa patients face urban obstacles and social misunderstanding

Retinitis pigmentosa is a degenerative genetic eye disease that severely restricts peripheral vision, leaving those affected with a narrow tunnel view of roughly 5 to 7 degrees per eye compared to the normal 180 degrees. As the leading…

Retinitis pigmentosa patients face urban obstacles and social misunderstanding

Retinitis pigmentosa is a degenerative genetic eye disease that severely restricts peripheral vision, leaving those affected with a narrow tunnel view of roughly 5 to 7 degrees per eye compared to the normal 180 degrees. As the leading genetic cause of blindness in adults, the condition progressively destroys retinal cells, making it persistently challenging to move through urban environments.

Living With Tunnel Vision and Daily Obstacles

Aitor Beraiz, a 48-year-old resident of Irun diagnosed at age 27, explains that while he can spot a coin on the ground, he routinely misses larger objects outside his narrow visual field. According to Beraiz and fellow patient Ana Grijalba, who was also diagnosed at 27, public misunderstandings often compound the daily strain of low vision.

Urban architecture frequently lacks accommodations for low-vision pedestrians, creating friction when people accidentally collide on crowded sidewalks. Grijalba notes that society’s reliance on smartphones means hurried pedestrians rarely watch for others, forcing individuals with retinitis pigmentosa to shoulder the burden of constant evasion. Simple adjustments, such as removing redundant bollards or painting necessary street fixtures in high-contrast, bright colors implemented in cities like Vitoria, significantly improve street accessibility.

The Psychological and Social Toll

Beyond physical obstacles, the psychological impact of progressive vision loss creates high levels of daily stress. Beraiz experiences acute photophobia when transitioning from bright outdoor light into darker environments, causing momentary blindness that triggers anxiety over public perception. Grijalba points out that social misunderstanding hurts more than the physical disability itself, noting that casual encounters at grocery store checkout counters or brief sidewalk greetings often fail because others do not realize how narrow her field of view truly is.

To mitigate these misunderstandings, Grijalba wears a low-vision distinguishing badge to signal her condition to those around her. Both patients emphasize that clear verbal cues, such as identifying directions by clock positions or explicitly announcing departures, help prevent awkward interactions and ease the constant tension of public movement.

Medical Outlook and Research Efforts

Retinitis pigmentosa remains an incurable degenerative ophthalmological condition that cannot be corrected with standard eyeglasses or traditional surgery. Grijalba highlights ongoing experimental treatments under evaluation by BioGipuzkoa, which researchers hope will eventually reach clinical trial phases to help slow disease progression and preserve remaining sight. Regional patient organizations, such as the association Begisare, actively fund ongoing research projects, provide public awareness campaigns, and offer comprehensive administrative and psychological support to newly diagnosed individuals dealing with the complexities of vision loss.

Frequently Asked Questions

What is retinitis pigmentosa?

Retinitis pigmentosa is a group of inherited disorders that progressively degrade the retina, leading to severe peripheral vision loss and eventual blindness.

Can retinitis pigmentosa be corrected with glasses?

No, standard prescription eyeglasses and conventional surgical procedures cannot correct the vision loss caused by retinitis pigmentosa.

How does tunnel vision affect daily mobility?

Tunnel vision restricts a person’s field of view to just a few degrees, making it difficult to detect side obstacles, uneven stairs, or moving pedestrians without active scanning.

A Patient's View of Retinitis Pigmentosa
About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”